Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development
Qian Wang, Jessamy Tiffen, Charles G. Bailey, et al.
JNCI Journal of the National Cancer Institute (2013) Vol. 105, Iss. 19, pp. 1463-1473
Closed Access | Times Cited: 165

Showing 1-25 of 165 citing articles:

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
Michelle van Geldermalsen, Qian Wang, Rajini Nagarajah, et al.
Oncogene (2015) Vol. 35, Iss. 24, pp. 3201-3208
Open Access | Times Cited: 520
mTORC1 as the main gateway to autophagy
Yoana Rabanal‐Ruiz, Elsje G. Otten, Viktor I. Korolchuk
Essays in Biochemistry (2017) Vol. 61, Iss. 6, pp. 565-584
Open Access | Times Cited: 477
Amino acid transporters revisited: New views in health and disease
Palanivel Kandasamy, Gergely Gyimesi, Yoshikatsu Kanai, et al.
Trends in Biochemical Sciences (2018) Vol. 43, Iss. 10, pp. 752-789
Closed Access | Times Cited: 383
Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development
Qian Wang, Rae‐Anne Hardie, Andrew J. Hoy, et al.
The Journal of Pathology (2015) Vol. 236, Iss. 3, pp. 278-289
Open Access | Times Cited: 302
Regulation of cancer cell metabolism: oncogenic MYC in the driver’s seat
Yang Dong, Rongfu Tu, Hudan Liu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 263
L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.
Qian Wang, Jeff Holst
PubMed (2015) Vol. 5, Iss. 4, pp. 1281-94
Closed Access | Times Cited: 256
Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot
Deborah C. I. Goberdhan, Clive Wilson, Adrian L. Harris
Cell Metabolism (2016) Vol. 23, Iss. 4, pp. 580-589
Open Access | Times Cited: 248
Targeting Cdc20 as a novel cancer therapeutic strategy
Lixia Wang, Jinfang Zhang, Lixin Wan, et al.
Pharmacology & Therapeutics (2015) Vol. 151, pp. 141-151
Open Access | Times Cited: 227
Targeting glutamine transport to suppress melanoma cell growth
Qian Wang, Kimberley A. Beaumont, Nicholas Otte, et al.
International Journal of Cancer (2014) Vol. 135, Iss. 5, pp. 1060-1071
Open Access | Times Cited: 208
The Metabolic Phenotype of Prostate Cancer
Eric Eidelman, Jeffrey Twum‐Ampofo, Jamal Akhtar Ansari, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 198
Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis
Ming Yue, Jue Jiang, Peng Gao, et al.
Cell Reports (2017) Vol. 21, Iss. 13, pp. 3819-3832
Open Access | Times Cited: 182
SLC transporters: structure, function, and drug discovery
Claire Colas, Peter M.U. Ung, Avner Schlessinger
MedChemComm (2016) Vol. 7, Iss. 6, pp. 1069-1081
Open Access | Times Cited: 180
The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
Pascal Häfliger, Roch‐Philippe Charles
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2428-2428
Open Access | Times Cited: 180
Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics
Yoshikatsu Kanai
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107964-107964
Closed Access | Times Cited: 155
L-Type amino acid transporter 1 as a target for drug delivery
Elena Puris, Mikko Gynther, Seppo Auriola, et al.
Pharmaceutical Research (2020) Vol. 37, Iss. 5
Open Access | Times Cited: 140
Metabolic reprogramming in prostate cancer
Fahim Ahmad, Murali Cherukuri, Peter L. Choyke
British Journal of Cancer (2021) Vol. 125, Iss. 9, pp. 1185-1196
Open Access | Times Cited: 137
Amino acid metabolism in tumor biology and therapy
Jie Chen, Likun Cui, Shaoteng Lu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 68
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer
Martin Bakht, Himisha Beltran
Nature Reviews Urology (2024)
Closed Access | Times Cited: 19
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis
Liu Pin, Meng-Meng Ge, Junjie Hu, et al.
Hepatology (2017) Vol. 66, Iss. 1, pp. 167-181
Open Access | Times Cited: 153
LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter
Lara Napolitano, Mariafrancesca Scalise, Michele Galluccio, et al.
The International Journal of Biochemistry & Cell Biology (2015) Vol. 67, pp. 25-33
Closed Access | Times Cited: 131
Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1
Natesh Singh, Gerhard F. Ecker
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1278-1278
Open Access | Times Cited: 122
Tumour metabolism and its unique properties in prostate adenocarcinoma
David Bader, Sean E. McGuire
Nature Reviews Urology (2020) Vol. 17, Iss. 4, pp. 214-231
Closed Access | Times Cited: 119
Cross-talk between protein synthesis, energy metabolism and autophagy in cancer
Lisa Lindqvist, Kristofferson Tandoc, Ivan Topisirović, et al.
Current Opinion in Genetics & Development (2017) Vol. 48, pp. 104-111
Open Access | Times Cited: 116
Molecular pathways and targets in prostate cancer
Emma Shtivelman, Tomasz M. Beer, Christopher P. Evans
Oncotarget (2014) Vol. 5, Iss. 17, pp. 7217-7259
Open Access | Times Cited: 107
The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model
Pascal Häfliger, Julien Graff, Matthias Rubin, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top